The company’s industrial plant in Camaçari, Bahia, has been recognized for its good manufacturing practices for pharmaceutical excipients; products bearing this seal gain greater credibility in the international market.
Camaçari, March 2025 – The industrial unit in Camaçari (BA) of Indovinya, the specialty chemicals business division of Indorama Ventures, has received the EXCiPACT certification, a global recognition of good manufacturing practices for pharmaceutical excipients—inactive substances used in drug formulations to provide specific characteristics to the final product. This is the first manufacturing plant in Brazil to earn this seal from the IPEC Federation, a global organization that promotes quality in pharmaceutical excipients.
The certification ensures that the company’s excipients meet the highest international standards of quality, safety, and traceability. “This certification strengthens Brazil’s participation in the global pharmaceutical industry. Companies that use certified excipients ensure the quality of their medicines, providing safe products to the end consumer,” explains Fabiana Marra, Marketing & R&D Director for Nutrition & Health at Indovinya.
According to her, the certification is a testament to Indovinya’s credibility and consistency in manufacturing processes, which excellently meet the sector’s demands. “With this achievement, Brazil can position itself as a regional reference in high-quality pharmaceutical excipients, while also reinforcing Indovinya’s commitment to safety, supply, and the availability of our products,” Marra adds.
Indovinya’s EXCiPACT certification covers the production of Polyethylene Glycols (PEGs), essential excipients for the pharmaceutical industry. This is an international voluntary initiative led by the IPEC Federation, which provides independent third-party certifications for manufacturers, suppliers, and distributors of pharmaceutical excipients worldwide, helping to ensure the quality and safety of audited suppliers’ products.
About Indorama Ventures
Indorama Ventures Public Company Limited, listed in Thailand (Bloomberg ticker IVL.TB), is one of the leading global petrochemical producers, with manufacturing in Europe, Africa, the Americas, and Asia-Pacific. The company’s portfolio includes Combined PET (CPET) – a business vertical that also encompasses integrated PEO, integrated EG, and MTBE assets – as well as Integrated Oxides and Derivatives (IOD), Indovida, and Fibers. Its products serve key FMCG and automotive sectors, including beverages, hygiene, personal care, tires, and safety. With around 26,000 employees worldwide, it generated revenue of $15.6 billion in 2023. The company is listed on the Dow Jones Emerging Markets and World Sustainability Indices (DJSI). In 2024, its IOD segment was renamed Indovinya.